Breaking News Instant updates and real-time market news.

SBPH

Spring Bank Pharmaceuticals

$5.06

0.33 (6.98%)

04:55
07/17/19
07/17
04:55
07/17/19
04:55

Spring Bank Pharmaceuticals management to meet with Piper Jaffray

Meeting to be held in San Francisco, CA on July 17 hosted by Piper Jaffray.

  • 17

    Jul

SBPH Spring Bank Pharmaceuticals
$5.06

0.33 (6.98%)

08/14/18
PIPR
08/14/18
INITIATION
Target $25
PIPR
Overweight
Spring Bank Pharmaceuticals initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff started Spring Bank Pharmaceuticals with an Overweight rating and $25 price target. The company has reported "encouraging" proof-of-concept data from the first three cohorts of the Phase II study of monotherapy inarigivir, in development to treat hepatitis B virus infection, Tenthoff tells investors in a research note. The analyst sees inarigivir as the "essential" immunomodulatory component in combination therapy to achieve an HBV functional cure.
10/09/18
JEFF
10/09/18
INITIATION
Target $28
JEFF
Buy
Spring Bank Pharmaceuticals initiated with a Buy at Jefferies
Jefferies analyst Maury Raycroft started Spring Bank Pharmaceuticals with a Buy rating and $28 price target. The company is developing inarigivir for hepatitis B virus and the drug is "de-risked" given its dose response and "excellent" safety profile, Raycroft tells investors in a research note. He believes inarigivir "could position as a backbone now and for the longer-term" in HBV treatment.
12/07/18
PIPR
12/07/18
NO CHANGE
Target $25
PIPR
Overweight
Spring Bank Pharmaceuticals R&D day highlights inarigivir, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff kept his Overweight rating and $25 price target on Spring Bank Pharmaceuticals after its R&D presentation yesterday. The analyst says the event highlighted the potency of inarigivir in Hepatitis B virus in patients as early as 12 weeks. Tenthoff further cites the final ACHIEVE data on the treatment likely coming at the EASL event in April of 2019, with additional studies taking place later next year.
07/01/19
PIPR
07/01/19
NO CHANGE
Target $10
PIPR
Overweight
Spring Bank price target lowered to $10 from $25 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff noted that Spring Bank Pharmaceuticals announced it has filed an Investigational New Drug application, or IND, on SB 11285, which he said is the first intravenous administered STING agonist to advance to the clinic. After pushing out his expectation for inarigavir approval, increasing his discount rate and rolling forward his discount period, Tenthoff reset his price target on Spring Bank shares to $10 from $25. He keeps an Overweight rating on the stock.

TODAY'S FREE FLY STORIES

BAYRY

Bayer

$0.00

(0.00%)

11:56
07/22/19
07/22
11:56
07/22/19
11:56
Periodicals
Bayer's Iberogast under investigation for connection to death, MarketWatch says »

Bayer's digestive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SE

Sea Limited

$35.15

0.49 (1.41%)

11:55
07/22/19
07/22
11:55
07/22/19
11:55
Options
Sea Limited put volume heavy and directionally bearish »

Bearish flow noted in Sea…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$47.02

1.51 (3.32%)

, TSLA

Tesla

$256.90

-1.22 (-0.47%)

11:45
07/22/19
07/22
11:45
07/22/19
11:45
On The Fly
Micron upgrade, Tesla downgrade among today's top analyst calls »

Check out today's top…

MU

Micron

$47.02

1.51 (3.32%)

TSLA

Tesla

$256.90

-1.22 (-0.47%)

SFIX

Stitch Fix

$27.18

0.27 (1.00%)

NDAQ

Nasdaq

$101.74

0.02 (0.02%)

ICE

IntercontinentalExchange

$90.40

-0.34 (-0.37%)

AAPL

Apple

$206.04

3.42 (1.69%)

UBER

Uber

$43.60

0.42 (0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 24

    Jul

  • 30

    Jul

  • 01

    Aug

  • 03

    Aug

  • 06

    Aug

  • 06

    Aug

  • 08

    Aug

APRN

Blue Apron

$8.93

0.58 (6.95%)

11:45
07/22/19
07/22
11:45
07/22/19
11:45
Options
Blue Apron call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

CARA

Cara Therapeutics

$25.78

-0.13 (-0.50%)

11:42
07/22/19
07/22
11:42
07/22/19
11:42
Recommendations
Cara Therapeutics analyst commentary at H.C. Wainwright »

Cara Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:36
07/22/19
07/22
11:36
07/22/19
11:36
General news
6-Month Bill Auction Total Amount data reported »

6-Month Bill Auction…

11:36
07/22/19
07/22
11:36
07/22/19
11:36
General news
3-Month Bill Auction Total Amount data reported »

3-Month Bill Auction…

MRNA

Moderna

$14.03

-0.07 (-0.50%)

11:34
07/22/19
07/22
11:34
07/22/19
11:34
Conference/Events
Moderna management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jul

  • 30

    Jul

  • 09

    Sep

DIOD

Diodes

$37.88

0.44 (1.18%)

11:28
07/22/19
07/22
11:28
07/22/19
11:28
Periodicals
Diodes mentioned cautiously by 'Cold Shower Analytics' 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Aug

CRON

Cronos Group

$14.55

-0.41 (-2.74%)

11:25
07/22/19
07/22
11:25
07/22/19
11:25
Options
Cronos Group call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

MDWD

MediWound

$3.76

0.04 (1.08%)

11:25
07/22/19
07/22
11:25
07/22/19
11:25
Conference/Events
MediWound to host analyst day »

Analyst day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

11:25
07/22/19
07/22
11:25
07/22/19
11:25
Conference/Events
The Board of Governors of the Federal Reserve System to hold a meeting »

Closed Board Meeting to…

GIS

General Mills

$52.28

-0.5 (-0.95%)

, DNKN

Dunkin' Brands

$79.45

-0.63 (-0.79%)

11:19
07/22/19
07/22
11:19
07/22/19
11:19
Hot Stocks
Dunkin' Brands appoints Stephanie Lilak as Chief Human Resources Officer »

Dunkin' Brands…

GIS

General Mills

$52.28

-0.5 (-0.95%)

DNKN

Dunkin' Brands

$79.45

-0.63 (-0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
07/22/19
07/22
11:17
07/22/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
07/22/19
07/22
11:16
07/22/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIO

Rio Tinto

$60.52

-0.6 (-0.98%)

11:15
07/22/19
07/22
11:15
07/22/19
11:15
Options
Rio Tinto put volume heavy and directionally bearish »

Bearish flow noted in Rio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

11:15
07/22/19
07/22
11:15
07/22/19
11:15
General news
FX Action: USD-JPY »

FX Action: USD-JPY traded…

11:15
07/22/19
07/22
11:15
07/22/19
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

11:15
07/22/19
07/22
11:15
07/22/19
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

NTEC

Intec Pharma

$0.47

-2.5179 (-84.21%)

11:11
07/22/19
07/22
11:11
07/22/19
11:11
Downgrade
Intec Pharma rating change  »

Intec Pharma downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTC

MMTEC

$17.20

0.1 (0.58%)

11:11
07/22/19
07/22
11:11
07/22/19
11:11
Hot Stocks
Breaking Hot Stocks news story on MMTEC 

MMTec Inc trading resumes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOSBF

Toshiba, also use TOSYY

$0.00

(0.00%)

, TOSYY

Toshiba, also use TOSBF

$0.00

(0.00%)

11:07
07/22/19
07/22
11:07
07/22/19
11:07
On The Fly
Micron rises as Goldman Sachs gets more positive on memory stocks, says Buy »

Shares of Micron (MU) are…

TOSBF

Toshiba, also use TOSYY

$0.00

(0.00%)

TOSYY

Toshiba, also use TOSBF

$0.00

(0.00%)

MU

Micron

$46.74

1.23 (2.70%)

MRVL

Marvell

$25.86

-0.04 (-0.15%)

AMAT

Applied Materials

$49.94

2.15 (4.50%)

LRCX

Lam Research

$205.90

7.47 (3.76%)

KLAC

KLA-Tencor

$134.27

2.32 (1.76%)

KEYS

Keysight Technologies

$87.03

-0.4 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 05

    Aug

DRRX

Durect

$0.86

0.1336 (18.46%)

, GILD

Gilead

$64.87

-0.17 (-0.26%)

11:05
07/22/19
07/22
11:05
07/22/19
11:05
Recommendations
Durect, Gilead analyst commentary at H.C. Wainwright »

Gilead pact offers…

DRRX

Durect

$0.86

0.1336 (18.46%)

GILD

Gilead

$64.87

-0.17 (-0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 30

    Jul

  • 07

    Aug

  • 09

    Sep

AG

First Majestic

$10.17

0.27 (2.73%)

11:05
07/22/19
07/22
11:05
07/22/19
11:05
Options
First Majestic call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GILD

Gilead

$64.98

-0.06 (-0.09%)

11:03
07/22/19
07/22
11:03
07/22/19
11:03
Hot Stocks
Gilead presents proof-of-concept data for GS-6207 in people living with HIV »

Gilead Sciences presented…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 30

    Jul

  • 07

    Aug

  • 09

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.